C Shad Thaxton

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 5

Top Topics

Immune Response

Low Density Lipoprotein

Top Venues

Molecular pharmaceutics

Journal of the American Chemical Society

This page only lists publications with an associated author ORCID identifier.

Publications

Kaylin M McMahon, Andrea E Calvert, Irina S Dementieva, Saber Hussain, John T Wilkins, C Shad Thaxton
Interparticle Molecular Exchange of Surface Chemical Components of Native High-Density Lipoproteins to Complementary Nanoparticle Scaffolds. ACS sensors 5 (10) (2020)
Stephen E Henrich, Bong Jin Hong, Jonathan S Rink, SonBinh T Nguyen, C Shad Thaxton
Supramolecular Assembly of High-Density Lipoprotein Mimetic Nanoparticles Using Lipid-Conjugated Core Scaffolds. Journal of the American Chemical Society 141 (25) (2019)
Abhalaxmi Singh, Vikas Nandwana, Jonathan S Rink, Soo-Ryoon Ryoo, Tzu Hung Chen, Sean David Allen, Evan Alexander Scott, Leo I Gordon, C Shad Thaxton, Vinayak P Dravid
Biomimetic Magnetic Nanostructures: A Theranostic Platform Targeting Lipid Metabolism and Immune Response in Lymphoma. ACS nano 13 (9) (2019)
Jonathan S Rink, Wangqiang Sun, Sol Misener, Jiao-Jing Wang, Zheng Jenny Zhang, Melina R Kibbe, Vinayak P Dravid, Subramanian S Venkatraman, C Shad Thaxton
Nitric Oxide-Delivering High-Density Lipoprotein-like Nanoparticles as a Biomimetic Nanotherapy for Vascular Diseases. ACS applied materials & interfaces 10 (8) (2018)
Jonathan S Rink, Shuo Yang, Osman Cen, Tim Taxter, Kaylin M McMahon, Sol Misener, Amir Behdad, Richard Longnecker, Leo I Gordon, C Shad Thaxton
Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin. Molecular pharmaceutics 14 (11) (2017)